Metabole GLP-1 therapie: leefstijl én medicatie | webinar dr. Yvo Sijpkens

Internist Dr. Yvo Sijpkens on metabolic GLP-1 therapy: how GLP-1 medication (such as Ozempic, Wegovy, and Mounjaro) and a low-carbohydrate lifestyle reinforce each other. Not an either-or, but a both-and — lifestyle tackles the cause, and medication can help turn the tide if necessary. In short: 1 plus 1 equals 3. In this webinar (July 8, 2026) by the Je Leefstijl Als Medicijn Foundation, you will discover how hyperinsulinemia is the silent engine behind overweight and chronic disease, how the hormone GLP-1 regulates hunger and satiety, what GLP-1 medications do — as well as their downsides such as muscle loss and relapse — and how therapeutic carbohydrate restriction (TKB) addresses the cause and ensures the result. ⏱️ Chapters 0:00 Intro 0:06 Introduction & Structure 5:19 Block 1 — Metabolic Dysfunction 12:40 Block 2 — Biology of GLP-1 23:25 Block 3 — GLP-1 Medication 44:56 Block 4 — Therapeutic Carbohydrate Restriction 1:01:38 Questions & Answers 1:33:50 Conclusion 👨‍⚕️ About Dr. Yvo Sijpkens Yvo Sijpkens is an internist and medical advisor to the Je Leefstijl Als Medicijn Foundation. He combines the latest medical developments with evidence-based lifestyle medicine and guides people on therapeutic carbohydrate restriction towards metabolic recovery. 📖 Read more • GLP-1 medicines and weight loss (sustainable results with carbohydrate restriction): https://jeleefstijlalsmedicijn.nl/glp... • Therapeutic carbohydrate restriction (lifestyle treatment for obesity, diabetes, and cardiovascular disease): https://jeleefstijlalsmedicijn.nl/the... • More about us: https://jeleefstijlalsmedicijn.nl Not medical advice. Always consult your own doctor regarding questions about medication or treatment. #GLP1 #Ozempic #leefstijlalsmedicijn #metabolichealth #lowcarb #weightloss #diabetes #lifestylemedicine #YvoSijpkens